Assessment of Abraxane in Metastatic Breast Cancer in a Real-life Setting
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Celgene Corporation
- 22 Feb 2017 Status changed from recruiting to completed.
- 11 Oct 2016 Results (n=203) assessing safety and efficacy presented at the 41st European Society for Medical Oncology Congress.
- 23 Sep 2015 New trial record